Vertaling van "thromboembolism with oral contraceptives containing " (Nederlands → Frans) :

(Jick 2006) Jick SS, Kaye JA, Russmann S, Jick H. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or
(Jick 2006) Jick SS, Kaye JA, Russmann S, Jick H. Risk of nonfatal venous thromboembolism with oral contraceptives containing

Risk of venous thromboembolism in users of oral contraceptives containing
Risk of venous thromboembolism in users of oral contraceptives

Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone
Risk of non-fatal venous thromboembolism in women using oral contraceptives containing

desogestrel compared with oral contraceptives containing levonorgestrel.
norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.

compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data. BMJ
drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States

Oral contraceptives containing drospirenone for premenstrual syndrome.
Oral contraceptives containing drospirenone for premenstrual

(Lidegaard 2011) Lidegaard Ø, Hougaard L, Wessel Skovlund C et al. Risk of venous thromboembolism from use of oral contraceptives
(Lidegaard 2011) Lidegaard Ø, Hougaard L, Wessel Skovlund C et al. Risk of venous thromboembolism from use of oral

Naar D.M. Grabrick et al.: Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer.
D’après D.M. Grabrick et al.: Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer.